| RS2464203420 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464204681 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS2464205035 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464209193 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464209283 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464242372 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2464283434 |
HMGCS2
|
Health Risk |
Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS2464382555 |
FLVCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464382987 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2464383008 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464383340 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464383347 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464383506 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464383788 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464385404 |
FLVCR1
|
Health Risk |
Likely pathogenic |
Posterior column ataxia-retinitis pigmentosa syndrome, Posterior column ataxia-retinitis pigmentosa syndrome |
| RS2464391048 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2464391439 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464391471 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464391538 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464391547 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464391737 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464391981 |
USH2A
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 36, Autosomal dominant nonsyndromic hearing loss 36 |
| RS2464393390 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464394047 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464394078 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464394129 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464394351 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2464394481 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464394589 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464394627 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464395714 |
NEK2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2464407470 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464408563 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464419297 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464419372 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464419618 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464419631 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464420419 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464420459 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464443860 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464443951 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464447576 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464453425 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464453903 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2464454319 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464454456 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464454827 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464454878 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464486306 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464489779 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464500607 |
FLVCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2464500667 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464500986 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464501346 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464503884 |
CACNA1S
|
Health Risk |
Likely pathogenic |
CACNA1S-related disorder, CACNA1S-related disorder |
| RS2464509136 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464509310 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464509424 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464509489 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464509726 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464518149 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464519932 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464520346 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464520593 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464520880 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464521243 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2464521290 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464534175 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464536840 |
CACNA1S
|
Health Risk |
Pathogenic |
Congenital myopathy 18, Congenital myopathy 18 |
| RS2464539498 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464539907 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464546834 |
CACNA1S
|
Health Risk |
Pathogenic |
Congenital myopathy 18, Congenital myopathy 18 |
| RS2464547155 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2464548163 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2464548279 |
TGFB2
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2464548369 |
TGFB2
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2464548803 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2464549208 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2464549704 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2464550705 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS2464555363 |
RD3
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 12, Leber congenital amaurosis 12 |
| RS2464559610 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464567071 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS2464577479 |
KCTD3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464580469 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2464585937 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464586085 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2464586115 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2464586191 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464587956 |
ARF1
|
Health Risk |
Pathogenic |
— |
| RS2464589957 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464590088 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS2464605797 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464606136 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2464606585 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464610781 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464611712 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2464611968 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2464612427 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2464613552 |
CACNA1S
|
Health Risk |
Pathogenic |
— |